Skip to main content
Log in

Epstein-Barr virus (EBV), lymphocytes and transformation

  • Guest Editorial
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Allan M, Harrison P (1980) Co-expression of differentiation markers in hybrids between Friend cells and lymphoid cells and the influence of cell shape. Cell 19:437–447

    PubMed  Google Scholar 

  • Aya T, Osato T (1974) Early events in transformation of human cord lymphocytes by Epstein-Barr virus: Induction of DNA synthesis mitosis and the virus-associated nuclear antigen synthesis. Int J Cancer 14:341–347

    PubMed  Google Scholar 

  • Baron D, Strominger L (1978) Partial purification and properties of the Epstein-Barr virus-associated nuclear antigen. J Biol Chem 253:2875–2881

    PubMed  Google Scholar 

  • Béchet JM, Fialkow P, Nilsson K, Klein G (1974) Immunoglobulin synthesis and glucose-6-phosphate dehydrogenase as cell markers in human lymphoblastoid cell lines. Exp Cell Res 89:275–282

    PubMed  Google Scholar 

  • Ben-Sasson SA, Klein G (1981) Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymhoid lines. Int J Cancer 28:131–135

    PubMed  Google Scholar 

  • Ber R, Klein G, Moar M, Povey S, Rosén A, Westman A, Yefenof E, Zeuthen J (1978) Somatic cell hybrids between human lumphoma lines. IV. Establishment and characterization of a P3HR-1/Daudi hybrid. Int J Cancer 21:707–719

    PubMed  Google Scholar 

  • Berger R, Bernheim A, Weh H-J, Flandria G, Daniel M-T, Brouet J-C, Colbert N (1979) A new translocation in Burkitt's tumor cells. Hum Genet 53:111–112

    PubMed  Google Scholar 

  • Bornkamm GW, Delius H, Zimber U, Hudewentz J, Epstein MA (1980) Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs. J Virol 35:603–618

    PubMed  Google Scholar 

  • Christiansen G, Christiansen C, Zeuthen J (1983) Complex forms of mitochondrial DNA in human B-cells transformed by Epstein-Barr virus (EBV). J Cancer Res Clin Oncol 105:13–19

    PubMed  Google Scholar 

  • Clements GB, Klein G, Zeuthen J, Povey S (1976) The selection of somatic cell hybrids between human lymphoma cell lines. Somatic Cell Genet 2:309–324

    PubMed  Google Scholar 

  • Cohen MM, Sagi M, Ben-Zur Z, Schaap T, Voss R, Kohn G (1979) Ataxia telangiectasia: Chromosomal stability of continuous lymphoblastoid cell lines. Cytogenet Cell Genet 23:44–54

    PubMed  Google Scholar 

  • Collins SJ, Gallo RC; Gallagher RE (1977) Continuous growth and differentiation of human myeloid leukemia cells in suspension culture. Nature 270:347–350

    PubMed  Google Scholar 

  • Croce CM, Shander M, Martinis J, Cicurel L, D'Ancona GG, Koprowski H (1980a) Preferential retention of human chromosome 14 in mouse x human B cell hybrids. Eur J Immunol 10:486–488

    Google Scholar 

  • Croce C, Linnenbach A, Hall W, Steplewski Z, Koprowski H (1980b) Production of human hybridomas secreting antibodies to measles virus. Nature 288:488–489

    PubMed  Google Scholar 

  • Einhorn L, Ernberg I (1978) Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes. Int J Cancer 21:157–160

    PubMed  Google Scholar 

  • Engblom I, Ernberg I (1981) Ultraviolet inactivation of Epstein-Barr virus-induced nuclear antigen (EBNA), DNA and IgM synthesis in human B lymphocytes. Virology 112:228–239

    PubMed  Google Scholar 

  • Eskeland T, Klein E (1971) Isolation of 7S IgM and kappa chains from the surface membrane of tissue culture cells dervied from a Burkitt lymphoma. J Immunol 107:1368–1375

    PubMed  Google Scholar 

  • Fellous M, Kamoun M, Wiels J, Dausset J, Clements G, Zeuthen J, Klein G (1977) Induction of HLA expression in Daudi cells after cell fusion. Immunogenetics 5:423–436

    Google Scholar 

  • Fialkow PJ, Klein G, Gartler SM, Clifford P (1970) Clonal origin for individual Burkitt tumors. Lancet I:384–386

    Google Scholar 

  • Fialkow PJ, Klein E, Klein G, Clifford P, Singh S (1973) Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma. J Exp Med 138:89–102

    PubMed  Google Scholar 

  • Fleischmann EW, Prigogina EL (1977) Karyotype abnormalities of malignant lymphomas. Hum Genet 35:269–279

    PubMed  Google Scholar 

  • Fukuhara S, Rowley JD (1978) Chromosome 14 translocations in non-Burkitt lymphomas. Int J Cancer 22:14–21

    PubMed  Google Scholar 

  • Gergely L, Llein G, Ernberg I (1971) Appearance of Epstein-Barr virus associated antigens in infected Raij cells Virology 45:10–21

    PubMed  Google Scholar 

  • Given D, Kieff E (1978) DNA of Epstein-Barr virus. VI. Mapping of the internal tandem reiteration. J Virol 31:315–324

    Google Scholar 

  • Glaser R, Rapp F (1972) Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells. J Virol 10:288–296

    PubMed  Google Scholar 

  • Glaser R, Nonoyama M (1973) Epstein-Barr virus: Detection of genome in somatic cell hybrids of Burkitt lymphoblastoid cells. Science 179:492–493

    PubMed  Google Scholar 

  • Glaser R, Ablashi DV, Nonoyama M, Henle W, Easton J (1977) Enhanced oncogenic behavior of human and mouse cells after cellular hybridization with Burkitt tumor cells. Proc Natl Acad Sci USA 74:2574–2578

    PubMed  Google Scholar 

  • Graessmann A, Wolf H, Bornkamm GW (1980) Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA. Proc Natl Acad Sci USA 77:433–436

    PubMed  Google Scholar 

  • Graessmann A, Graessmann M, Mueller C (1981) Regulation of SV 40 gene expression. Adv Cancer Res 35:111–149

    PubMed  Google Scholar 

  • Grogan E, Miller G, Henle W, Rabson M, Shedd D, Niedermann JC (1981) Expression of Epstein-Barr viral early antigen in monolayer tissue cultures after transfection with viral DNA and DNA fragments. J Virol 40:861–869

    PubMed  Google Scholar 

  • Hayward S, Kieff E (1976) Epstein-Barr virus specific RNA. I. Analysis of viral RNA in cellular extracts and in polyribosomal fraction of permissive and non-permissive lymphoblastoid cell lines. J Virol 18:518–525

    PubMed  Google Scholar 

  • Hayward SD, Kieff E (1977) DNA of Epstein-Barr virus. II. Comparison of the molecular weights of restriction endonuclease fragments of the DNA of Epstein-Barr virus strains and identification of end fragments of the B95-8 strain. J Virol 23:421–429

    PubMed  Google Scholar 

  • Hengartner H, Meo T, Müller E (1978) Assignment of genes for immunoglobulin K and heavy chains to chromosomes 6 and 12 in mouse. Proc Natl Acad Sci USA 75:4494–4498

    PubMed  Google Scholar 

  • Henle G, Henle W (1966) Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol 91:1248–1256

    PubMed  Google Scholar 

  • Henle G, Henle W, Clifford P, Diehl V, Kafuko GW, Kirya BG, Klein G, Morrow RH, Munube GMR, Pike P, Takle PM, Ziegler JL (1969) Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst 43:1147–1157

    PubMed  Google Scholar 

  • Henle G, Henle W, Zajac B, Pearson G, Waubke R, Scriba M (1970) Differential reactivity of human sera with early antigens induced by Epstein-Barr virus. Science 169:188–190

    PubMed  Google Scholar 

  • Henle G, Henle W, Klein G, Gunvén P, Clifford P, Morrow RH, Ziegler JL (1971) Antibodies to early EBV-induced antigens in Burkitt's lymphoma. J Natl Cancer Inst 46:861–871

    PubMed  Google Scholar 

  • Hinuma Y, Ohta R, Miyamoto T, Ishida N (1962) Evaluation of the complement method of fluorescent antibody technique with myxoviruses. J. Immunol 89:19–26

    PubMed  Google Scholar 

  • Hunter T (1980) Proteins phosphorylated by the RSV transforming function. Cell 22:647–648

    PubMed  Google Scholar 

  • Ito Y (1980) Organization and expression of the genome of polyoma virus. In: Klein G (ed), Viral oncology, Raven Press, New York (pp 447–480)

    Google Scholar 

  • Jondal M, Klein G, Oldstone M, Bokish V, Yefenof E (1976) Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus (EBV) receptors on human lymphoid cells. Scand J Immunol 5:401–410

    PubMed  Google Scholar 

  • Jörnvall H, Luka J, Klein G, Appella E (1982) A 53 K protein common to chemically and virally transformed cells shows extensive sequence similarities between species. Proc Natl Acad Sci USA 79:287–291

    PubMed  Google Scholar 

  • Kaiser-McCaw B, Epstein AL, Kaplan AL, Hecht F (1977) Chromosome 14 translocation in African and North American Burkitt's lymphomas. Int J Cancer 19:482–486

    PubMed  Google Scholar 

  • Kamata T, Tanaka S, Aikawa S, Hinuma Y, Watanabe Y (1979) A possible function of Epstein-Barr virus-determined nuclear antigen (EBNA): Stimulation of chromatin template activity in vitro. Virology 95:222–226

    PubMed  Google Scholar 

  • Kamata T, Takaki K, Hinuma Y, Watanabe Y (1981) Protein kinase activity associated with the Epstein-Barr virus-determined nuclear antigen. Virology 113:512–520

    PubMed  Google Scholar 

  • Kaschka-Dierich C, Adams A, Lindahl T, Bornkamm GW, Bjursell G, Klein G, Giovanella BC, Singh S (1976) Intracellular forms of Epstein-Barr virus DNA in human tumor cells in vivo. Nature 260:302–306

    PubMed  Google Scholar 

  • Kintner C, Sugden B (1981) Identification of antigenic determinants unique to the surface of cells transformed by Epstein-Barr virus. Nature 294:458–460

    PubMed  Google Scholar 

  • Klein G, Clifford P, Klein E, Stjernswärd J (1966) Search for tumor specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci USA 55:1628–1635

    PubMed  Google Scholar 

  • Klein G, Clifford P, Klein E, Stjernswärd J (1967) Membrane immunofluorescence reactions of Burkitt's lymphoma cells from biopsy specimens and tissue culture. J Natl Cancer Inst 39:1027–1044

    PubMed  Google Scholar 

  • Klein E, Eskeland T, Inoue M, Strom R, Johansson B (1970) Surface immunoglobulin moieties on lymphoid cells. Exp Cell Res 62:133–148

    PubMed  Google Scholar 

  • Klein G, Wiener F, Zech L, zur Hausen H, Reedman B (1974) Segregation of the EBV-determined nuclear antigen (EBNA) in somatic cell hybrids derived from the fusion of a mouse fibroblast and a human Burkitt lymphoma line. Int J Cancer 14:54–64

    PubMed  Google Scholar 

  • Klein G, Clements G, Zeuthen J, Westman A (1976a) Somatic cell hybrids between human lymphoblastoid cel lines. II. Spontaneous and induced patterns of Epstein-Barr virus (EBV) cycle. Int J Cancer 17:715–724

    PubMed  Google Scholar 

  • Klein G, Zeuthen J, Terasaki P, Billing R, Honig R, Jondal M, Westman A, Clements G (1976b) Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines. Int J Cancer 18:639–625

    PubMed  Google Scholar 

  • Klein G, Clements G, Zeuthen J, Westman A (1977a) Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids. Cancer Lett 3:91–98

    PubMed  Google Scholar 

  • Klein G, Terasaki P, Billing R, Honig R, Jondal M, Rosén A, Zeuthen J, Clements G (1977b) Somatic cell hybrids between human lymphoma lines. III. Surface markers. Int J Cancer 19:66–76

    PubMed  Google Scholar 

  • Klein G (1978) Cancer, viruses, and environmental factors. In: Kurstak E, Maramorosch K (eds) Viruses and Environment Academic Press, New York, pp 1–12

    Google Scholar 

  • Klein G (1979) Lymphoma development in mice and humans: Diversity of initiation is followed by convergent cytogenetic evolution Proc Natl Acad Sci USA 76:2442–2446

    PubMed  Google Scholar 

  • Klein G, Luka J, Zeuthen J (1980a) Transformation induced by Epstein-Barr virus and the role of the nuclear antigen. Cold Spring Harbor Symp. Quant. Biol 44:253–261

    PubMed  Google Scholar 

  • Klein G, Zeuthen J, Eriksson I, Terasaki P, Bernoco M, Rosén A, Masucci G, Povey S, Ber R (1980b) Hybridization of a myeloid leukemia derived cell line (K562) with a Burkitt lymphoma line (P3HR-1) J Natl Cancer Inst 64:725–738

    PubMed  Google Scholar 

  • Klein G (1981) The role of gene dosage and genetic transpositions in carcinogenesis. Nature 294:313–318

    PubMed  Google Scholar 

  • Klein G, Zeuthen J, Ber R, Ernberg I (1982) Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns. J Natl Cancer Inst 68:197–202

    PubMed  Google Scholar 

  • Koeffler HP, Sparkes RS, Billings R, Klein G (1981) Somatic cell hybrid analysis of hematopoietic differentiation. Blood 58:1159–1163

    PubMed  Google Scholar 

  • Koskimies S (1980) A human lymphoblastoid cell line producing specific antibody against Rh-D antigen.Scand J Immunol 11:73–77

    PubMed  Google Scholar 

  • Kozbor D, Steinitz M, Klein G, Koskimies S, Mäkelä O (1979) Establishment of anti-TNP antibody producing human lymphoid lines by preselection for hapten binding followed by EBV transformation. Scand J Immunol 10:187–194

    PubMed  Google Scholar 

  • Kozbor D, Lagarde AE, Roder JC (1982) Human anti-tetanus toxoid monolonal antibodies produced by a human myeloma hybridized with an EB-virus transformed cell line. Proc Natl Acad Sci USA 79:6651–6655

    PubMed  Google Scholar 

  • Köhler G, Milstein C (1976) Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 6:511–519

    PubMed  Google Scholar 

  • Lane DP, Crawford LV (1979) T antigen is bound to a host protein in SV 40-transformed cells. Nature 278:261–263

    PubMed  Google Scholar 

  • Lau R, Nonoyama M, Klein G (1981) Somatic cell hybrids between human lymphoma and human myeloid leukemia cells. I. Induction of resident viral genome transcription and antigen formation by IUdR and TPA. Virology 110:259–269

    PubMed  Google Scholar 

  • Lindahl T, Klein G, Reedman BM, Johansson B, Singh S (1974) Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. Int J Cancer 13:764–772

    PubMed  Google Scholar 

  • Luka J, Siegert W, Klein G (1977) Solubilization of the Epstein-Barr virus-determined nuclear antigen and its characterization as a DNA-binding protein. J Virol 22:1–8

    PubMed  Google Scholar 

  • Luka J, Jörnvall H, Klein G (1980) Purification and biochemical characterization of the EBV-determined nuclear antigen (EBNA) and an associated protein with a 53 K subunit. J Virol 35:592–602

    PubMed  Google Scholar 

  • Malcolm S, Barton P, Bentley DL, Ferguson-Smith MA, Murphy CS, Rabbitts TH (1982) Assignment of a IGKV locus for immunoglobulin light chains to the short arm of chromosome-2 (2p13-cen) by in situ hybridization using a cRNA probe of HK 101 λ Ch4A. Cytogenet Cell Genet 32:296

    Google Scholar 

  • Manolov G, Manolova Y (1972) Marker band in one chromosome 14 from Burkitt lymphomas. Nature 237:33–34

    PubMed  Google Scholar 

  • Manolova Y, Manolov G, Kieler J, Levan A, Klein G (1979) Genesis of the 14q+ marker in Burkitt lymphoma. Hereditas 90:5–10

    PubMed  Google Scholar 

  • Mark J, Ekedahl C, Hagman A (1977) Origin of the translocated segment of the 14q+ marker in non-Burkitt lymphomas. Humangenetik 36:277–282

    Google Scholar 

  • Martin RG, Oppenheim A (1977) Initiation points for DNA replication in non-transformed and simian virus SV40-transformed Chinese hamster lung cells. Cell 11:859–869

    PubMed  Google Scholar 

  • Martin RG (1981) The transformation of cell growth and transmogrification of DNA synthesis by Simian Virus 40. Adv Cancer Res 34:1–68

    PubMed  Google Scholar 

  • Matsuoka Y, Takahashi Y, Yagi Y, Moore GE, Pressman D (1968) Synthesis and secretion of immunoglobulins by established cell lines of human hematopoietic origin. J Immunol 101:1111–1120

    PubMed  Google Scholar 

  • McBride W, Swan D, Leder P, Hieter P, Hollis G (1982) Chromosomal location of human immunoglobulin light chain constant region genes. Cytogenet Cell Genet 32:297–298

    Google Scholar 

  • McCaw KB, Hecht F, Harnden DG, Teplitz RJ (1975) Somatic rearrangement of chromosome 14 in human lymphocytes. Proc Natl Acad Sci USA 72:2071–2075

    PubMed  Google Scholar 

  • McConnell I, Klein G, Lint TF, Lachmann PJ (1978) Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells. Eur J Immunol 8:453–460

    PubMed  Google Scholar 

  • McKusick VA, Cross HE (1966) Ataxia-teleangiectasia and Swiss type agammaglobulinemia. JAMA 195:739–745

    PubMed  Google Scholar 

  • Menezes J, Jondal M, Leibold W, Dorval G (1976) Epstein-Barr virus interaction with human lymphocyte subpopulations: Virus adsorption, kinetics of expression of EBV-associated nuclear antigen (EBNA) and lymphocyte transformation. Infect Immun 13:303–310

    PubMed  Google Scholar 

  • Miller G, Lipman M (1973) Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 70:190–194

    PubMed  Google Scholar 

  • Miller G, Grogan E, Heston L, Robinson J, Smith D (1981) Epstein-Barr viral DNA: Infectivity for human placental cells. Science 212:452–455

    PubMed  Google Scholar 

  • Milner J, Milner S (1981) SV 40–53 K antigen: A possible role for 53K in normal cells. Virology 112:785–788

    PubMed  Google Scholar 

  • Mitelman F, Anvret-Andersson M, Brandt L, Catovsky D, Klein G, Manolov G, Manolova Y, Mark-Vendel E, Nilsson PG (1979) Reciprocal 8;14 translocation in EBV-negative B-cell acute lymphocytic leukemia and in a leukemic non-endemic Burkitt lymphoma. Int J Cancer 24:27–33

    PubMed  Google Scholar 

  • Mitelman F (1981) Marker chromosome 14q + in human cancer and leukemia. Adv Cancer Res 34:141–167

    PubMed  Google Scholar 

  • Moar MH, Ber R, Klein G, Westman A, Eriksson I (1978) Somatic cell hybrids between human lymphoma lines. V. IUdR inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines. Int J Cancer 22:669–680

    PubMed  Google Scholar 

  • Montagnier L, Gruest J (1979) Cell-density-dependence for growth in agarose of two human lymphoma lines and its decrease after Epstein-Barr virus conversion. Int J Cancer 23:71–76

    PubMed  Google Scholar 

  • Nadkarni JS, Nadkarni JJ, Clifford P, Manolov G, Fenyö EM, Klein E (1969) Characteristics of new cell lines derived from Burkitt lymphomas. Cancer 23:64–79

    PubMed  Google Scholar 

  • Nilsson K, Pontén J (1975) Classification and biological nature of established human hematopoietic cell lines. Int J Cancer 15:321–341

    PubMed  Google Scholar 

  • Nilsson K, Giovanella BC, Stehlin JS, Klein G (1977) Tumorigenity of human hematopoietic cell lines in athymic nude mice. Int J Cancer 20:337–344

    Google Scholar 

  • Nonoyama M, Pagano JS (1973) Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature 242:44–47

    PubMed  Google Scholar 

  • Nyormoi O, Klein G, Adams A, Dombos L (1973) Sensitivity to EBV superinfection and IUdR inducibility of hybrid cells formed between a sensitive and a relatively resistant Burkitt lymphoma cell line. Int J Cancer 12:396–408

    PubMed  Google Scholar 

  • Ohno S, Luka J, Lindahl T, Klein G (1977) Identification of a purified complement-fixing antigen as the Epstein-Barr virus nuclear antigen (EBNA) by its binding to metaphase chromosomes. Proc Natl Acad Sci USA 74:1605–1609

    PubMed  Google Scholar 

  • Olsson L, Kaplan HS (1980) Human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci USA 77:5429–5431

    PubMed  Google Scholar 

  • Oppenheim A, Shlomai Z, Ben-Bassat H (1981) Initiation points for cellular deoxyribonucleic acid replication in human lymphoid cells converted by Epstein-Barr virus. Mol Cell Biol 1:753–762

    PubMed  Google Scholar 

  • Orellana T, Kieff E (1977) Epstein-Barr virus specific RNA. II. Analysis of polyadenylated viral RNA in restringent, abortive and productive infections. J Virol 22:321–330

    PubMed  Google Scholar 

  • Otsuka H, Haxen M, Kit M, Quavi H, Kit S (1981) Cloning of the marmoset herpes virus thymidine kinase gene and analysis of the boundaries of the coding region. Virology 113:196–213

    PubMed  Google Scholar 

  • Pope JH (1979) Transformation by the virus in vitro. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp 205–223

    Google Scholar 

  • Povey S, Jeremiah S, Arthur E, Ber P, Fialkow PJ, Gardiner E, Goodfellow PN, Karande A, Klein G, Quintero M, Steel CM, Zeuthen J (1981) Deficiency of malic enzyme: A possible marker for malignancy in lymphoid cells. Ann Hum Genet 45:237–252

    PubMed  Google Scholar 

  • Pritchett RF, Hayward SD, Kieff ED (1975) DNA of Epstein-Barr virus. I. Comparative studies of the DNA of Epstein-Barr virus from HR-1 and B95-8 cells: Size, structure, and relatedness. J Virol 15:556–569

    PubMed  Google Scholar 

  • Purtilo DT, Sakamoto K, Saemundsen AK, Sullivan JL, Synnerholm AC, Anvret M, Pritchard M, Sloper C, Sieff C, Pincott J, Pachman L, Rich K, Cruzi F, Cornet JA, Collins R, Barnes N, Knight J, Sandstedt B, Klein G (1981) Documentation of Epstein-Barr virus infection in immunodeficient patients with lifethreatening lymphoproliferative diseases by clinical, virological, and immunopathological studies. Cancer Res 41:4226–4236

    PubMed  Google Scholar 

  • Raab-Traub N, Pritchett R, Kieff E (1978) DNA of Epstein-Barr virus. III. Identification of restriction enzymes that contain DNA sequences which differ among strains of Epstein-Barr virus. J Virol 27:388–398

    PubMed  Google Scholar 

  • Reedman BM, Klein G (1973) Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and nonproducer lymphoblastoid cell lines. Int J Cancer 11:499–520

    PubMed  Google Scholar 

  • Rickinson AB, Moss DJ, Wallace LE, Rowe M, Misko IS, Epstein MA, Rope JH (1981) Long-term T-cell mediated immunity to Epstein-Barr virus. Cancer Res 41:4216–4221

    PubMed  Google Scholar 

  • Ringertz NR, Savage RE (1976) Cell hybrids. Academic Press, New York

    Google Scholar 

  • Robinson J, Miller G (1975) Assay for Epstein-Barr virus based on the stimulation of DNA synthesis in mixed leukocytes from human umbilical blood. J Virol 15:1065–1072

    PubMed  Google Scholar 

  • Rosa MD, Gottlieb E, Lerner MR, Steitz JA (1981) Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol Cell Biol 1:785–786

    PubMed  Google Scholar 

  • Rosén A, Britton S, Gergely P, Jondal M, Klein G (1977a) Epstein-Barr virus infection of human lymphocytes in vivo. Nature 267:52–54

    PubMed  Google Scholar 

  • Rosén A, Clements G, Klein G, Zeuthen J (1977b) Double immunoglobulin production in cloned somatic cell hybrids between two human lymphoid lines. Cell 11:139–147

    PubMed  Google Scholar 

  • Rosental KS, Shuman H, Strominger JL (1981) Induction of several new antigens including a T cell-associated antigen, following conversion of the EBV-negative B cell line Ramos to EHR-B Ramos by Epstein-Barr virus. J Immunol 127:746–754

    PubMed  Google Scholar 

  • Roubal J, Klein G (1981) Synthesis of thymidine kinase (TK) in Epstein-Barr virus-superinfected Raji TK-negative cells. Intervirology 15:43–48

    PubMed  Google Scholar 

  • Roubal J, Källin B, Luka J, Klein G (1981) Early DNA-binding polypeptides of Epstein-Barr virus. Virology 113:285–292

    PubMed  Google Scholar 

  • Rowley JD (1980) Chromosome abnormalities in cancer. Cancer Genet Cytogenet 2:175–198

    Google Scholar 

  • Rutherford TR, Clegg JB, Weatherall DJ (1979) K562 human leukaemic cells synthesize embryonic haemolobin in response to haemin. Nature 280:164–165

    PubMed  Google Scholar 

  • Rymo L (1979) Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma derived cells. J Virol 32:8–18

    PubMed  Google Scholar 

  • Rymo L, Lindahl T, Adams A (1979) Sites of sequence variability in Epstein-Barr virus DNA from different sources. Proc Natl Acad Sci USA 76:2794–2798

    PubMed  Google Scholar 

  • Rymo L, Lindahl T, Povey S, Klein G (1981) Analysis of restriction endonuclease fragments of intracellular Epstein-Barr virus DNA and isoenzymes indicate a common origin of the Raji, NC-37 and F-265 human lymphoid cell lines. Virology 115:115–124

    PubMed  Google Scholar 

  • Saemundsen AK, Purtilo DT, Sakamoto K, Sullivan JL, Synnerholm AC, Hanto DC, Simmons R, Anvret M, Collins R, Klein G (1981) Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res 41:4237–4242

    PubMed  Google Scholar 

  • Shaw JE, Levinger LF, Carter CW (1979) Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines. J Virol 29:657–665

    PubMed  Google Scholar 

  • Steel CM, Woodward MA, Davidson C, Philipson J, Arthur E (1977) Non-random chromosome gains in human lymphoblastiod cell lines. Nature 270:349–351

    PubMed  Google Scholar 

  • Steinitz M, Klein G (1975) Comparison between growth characteristics of an Epstein-Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro Proc Natl Acad Sci USA 72:3518–3520

    PubMed  Google Scholar 

  • Steinitz M, Klein G (1976) Epstein-Barr virus (EBV)-induced change in the saturation sensitivity and serum dependence of established, EBV-negative lymphoma lines in vitro. Virology 70:570–573

    PubMed  Google Scholar 

  • Steinitz M, Klein G (1977) Further studies on the differences in serum dependence in EBV negative lymphoma lines and their in vitro converted, virus-genome carrying sublines. Eur J Cancer 13:1269–1275

    PubMed  Google Scholar 

  • Steinitz M, Klein G, Koskimies S, Mäkelá O (1977) Epstein-Barr virus-induced B-lymphocyte cell lines producing specific antibody. Nature 269:420–422

    PubMed  Google Scholar 

  • Steinitz M, Seppälä I, Eichmann K, Klein G (1979) Establishement of a human lymphoblastoid cell line with specific antibody production against group A Streptococcal carbohydrate. Immunobiology 156:41–47

    PubMed  Google Scholar 

  • Steinitz M, Izak G, Cohen S, Ehrenfeld M, Fleehner J (1980) Continuous production of rheumatoid factor by in vitro EBV-transformed lymphocytes. Nature 287:443–445

    PubMed  Google Scholar 

  • Stenman S, Zeuthen J, Ringertz NR (1975) Expression of SV40 T antigen during the cell cycle of SV40-transformed cells. Int J Cancer 15:547–554

    PubMed  Google Scholar 

  • Svedmyr E, Jondal M (1975) Cytotoxic cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectuous mononucleosis. Proc Natl Acad Sci USA 72:1622–1626

    PubMed  Google Scholar 

  • Tanaka A, Nonoyama M, Glaser R (1977) Transcription of latent Epstein-Barr virus genomes in human epithelial/Burkitt hybrid cells. Virology 82:63–68

    PubMed  Google Scholar 

  • Tjian R, Fey G, Graessmann A (1978) Biological activity of purified simian virus 40 T antigen proteins. Proc Natl Acad Aci USA 75:1279–1284

    Google Scholar 

  • van Den Berghe H, Parloir C, Gosseye S, Englebienne V, Cornu G, Sokal G (1979) Variant translocation in Burkitt lymphoma. Cancer Genet Cytogenet 1:9–14

    Google Scholar 

  • van Furth R, Gorter H, Nadkarni JS, Klein E, Clifford P (1972) Synthesis of immunoglobulins by biopsied tissues and cell lines from Burkitt's lymphoma. Immunology 22:847–857

    PubMed  Google Scholar 

  • Volsky DJ, Shapiro IM, Klein G (1980) Transfer of Epstein-Barr virus receptors to receptor-negative cells permits virus penetration and antigen expression. Proc Natl Acad Sci USA 77:5453–5457

    PubMed  Google Scholar 

  • Volsky DJ, Klein G, Volsky B, Shapiro IM (1981) Production of infectious Epstein-Barr virus in mouse lymphocytes. Nature 293:399–401

    PubMed  Google Scholar 

  • Yefenof E, Klein G (1976) Difference in antibody induced redistribution of membrane IgM in EBV-genome free and EBV-carrying human lymphoma lines. Exp Cell Res 108:185

    Google Scholar 

  • Zech L, Haglund U, Nilsson K, Klein G (1976) Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 17:47–56

    PubMed  Google Scholar 

  • Zeuthen J, Stenman S (1976) Expression of SV40 T antigen during inhibition of DNA synthesis. Cancer Lett 1:219–224

    PubMed  Google Scholar 

  • Zeuthen J, Nilsson K (1976) Hybridization of a human myeloma permanent cell line with mouse cells. Cell Differ 4:369–383

    PubMed  Google Scholar 

  • Zeuthen J, Stenman S, Fabricius HÅ, Nilsson K (1976) Expression of immunoglobulin synthesis in human myeloma x nonlymphoid cell heterokaryons: Evidence for negative control. Cell Differ 4:369–383

    PubMed  Google Scholar 

  • Zeuthen J, Friedrich U, Rosén A, Klein E (1977) Structural abnormalities in chromosome 15 in cell lines with reduced expression of beta-2 microglobulin. Immunogenetics 4:567–580

    Google Scholar 

  • Zeuthen J, Klein G (1981) Some recent trends in studies of human lymphoid cells: B-cells, Epstein-Barr virus, and transformation. In Neth R, Gallo RC, Graf T, Mannweiler K, Winkler K (eds) Hematology and blood transfusion 26. Modern trends in human leukemia IV. Springer, Berlin Heidelberg, pp 179–190

    Google Scholar 

  • Zeuthen J, Klein G, Ber R, Masucci G, Bisballe S, Povey S, Terasaki P, Ralph P (1982) Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers. J Nat Cancer Inst 68:179–195

    PubMed  Google Scholar 

  • Ziegler A, Laudien D, Heinrichs H, Müller C, Uchańska-Ziegler B, Wernet P (1981) K562 cells express human major histocompatibility antigens. Immunogenetics 13:359–365

    PubMed  Google Scholar 

  • Ziegler A, Uchańska-Ziegler B, Zeuthen J, Wernet P (1982) HLA antigen expression at the single cell level on a K562 x B cell hybrid: An analysis with monoclonal antibodies. Somatic Cell Genet 8:775–789

    PubMed  Google Scholar 

  • zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L (1979a) EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228:1056–1058

    Google Scholar 

  • zur Hausen H, Bornkamm GW, Schmidt R, Hecker E (1979b) Tumor initiators and promotors in the induction of Epstein-Barr virus. Proc Natl Acad Sci USA 76:782–785

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The “Journal of Cancer Research and Clinical Oncology” publishes in loose succession “Editorials” and “Guest Editorials” on current and/or controversial problems in experimental and clinical oncology. These contributions represent exclusively the personal opinion of the author

Work in the author's laboratory was generously supported by grants from the Danish Natural Science and Medical Research Councils, the Danish Cancer Society, and an award from the Boel Foundation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zeuthen, J. Epstein-Barr virus (EBV), lymphocytes and transformation. J Cancer Res Clin Oncol 106, 1–11 (1983). https://doi.org/10.1007/BF00399890

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00399890

Navigation